

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Lack of Evidence for Changing Virulence of HIV-1 in North America</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001525"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001525" />

    <meta name="citation_title" content="Lack of Evidence for Changing Virulence of HIV-1 in North America"/>
    <meta itemprop="name" content="Lack of Evidence for Changing Virulence of HIV-1 in North America"/>

      <meta name="citation_author" content="Joshua T. Herbeck"/>
            <meta name="citation_author_institution" content="University of Washington School of Medicine, Seattle, Washington, United States of America"/>
      <meta name="citation_author" content="Geoffrey S. Gottlieb"/>
            <meta name="citation_author_institution" content="University of Washington School of Medicine, Seattle, Washington, United States of America"/>
      <meta name="citation_author" content="Xiuhong Li"/>
            <meta name="citation_author_institution" content="Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America"/>
      <meta name="citation_author" content="Zheng Hu"/>
            <meta name="citation_author_institution" content="Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America"/>
      <meta name="citation_author" content="Roger Detels"/>
            <meta name="citation_author_institution" content="University of California Los Angeles School of Public Health, Los Angeles, California, United States of America"/>
      <meta name="citation_author" content="John Phair"/>
            <meta name="citation_author_institution" content="Northwestern University Medical School, Chicago, Illinois, United States of America"/>
      <meta name="citation_author" content="Charles Rinaldo"/>
            <meta name="citation_author_institution" content="University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America"/>
      <meta name="citation_author" content="Lisa P. Jacobson"/>
            <meta name="citation_author_institution" content="Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America"/>
      <meta name="citation_author" content="Joseph B. Margolick"/>
            <meta name="citation_author_institution" content="Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America"/>
      <meta name="citation_author" content="James I. Mullins"/>
            <meta name="citation_author_institution" content="University of Washington School of Medicine, Seattle, Washington, United States of America"/>

    <meta name="citation_date" content="2008/2/6"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001525.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1525"/>
    <meta name="citation_issue" content="2"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Is the clinical course of HIV-1 changing? Cohort study.; citation_author=A Sinicco; citation_author=R Fora; citation_author=R Raiteri; citation_author=M Sciandra; citation_author=G Bechis; citation_journal_title=British Medical Journal; citation_volume=315; citation_number=1; citation_pages=1232-1237; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Association between the Rate of CD4+ T Cell Decrease and the Year of Human Immunodeficiency Virus (HIV) Type 1 Seroconversion among Persons Enrolled in the Swiss HIV Cohort Study.; citation_author=P Vanhems; citation_author=J Lambert; citation_author=M Guerra; citation_author=B Hirschel; citation_author=R Allard; citation_journal_title=J Infect Dis; citation_volume=180; citation_number=2; citation_pages=1803-1808; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002.; citation_author=M Dorrucci; citation_author=A Phillips; citation_author=B Longo; citation_author=G Rezza; citation_journal_title=AIDS; citation_volume=19; citation_number=3; citation_pages=331-335; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Temporal Trends in Postseroconversion CD4 Cell Count and HIV Load: The Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002.; citation_author=M Dorrucci; citation_author=G Rezza; citation_author=K Porter; citation_author=A Phillips; citation_journal_title=J Infect Dis; citation_volume=195; citation_number=4; citation_pages=525-534; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes.; citation_author=S Holmberg; citation_author=L Conley; citation_author=S Luby; citation_author=S Cohn; citation_author=L Wong; citation_journal_title=J Acquir Immune Defic Syndr Hum Retrovirol; citation_volume=9; citation_number=5; citation_pages=291-296; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion.; citation_author=T O'Brien; citation_author=D Hoover; citation_author=P Rosenberg; citation_author=B Chen; citation_author=R Detels; citation_journal_title=Am J Epidemiol; citation_volume=142; citation_number=6; citation_pages=636-642; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Temporal trends of initial CD4 cells counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study.; citation_author=N Galai; citation_author=A Lepri; citation_author=D Viahov; citation_author=P Pezzotti; citation_author=A Sinicco; citation_journal_title=Am J Epidemiol; citation_volume=143; citation_number=7; citation_pages=278-282; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active anti-retroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on Seroconversion to AIDS and Death in Europe.; citation_journal_title=Lancet; citation_volume=355; citation_number=8; citation_pages=1131-1137; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.; citation_journal_title=J Acquir Immune Defic Syndr; citation_volume=34; citation_number=9; citation_pages=76-83; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Stable virulence levels in the HIV epidemic of Switzerland over two decades.; citation_author=V MÃ¼ller; citation_author=B Ledergerber; citation_author=L Perrin; citation_author=T Klimkait; citation_author=H Furrer; citation_journal_title=Aids; citation_volume=20; citation_number=10; citation_pages=889-894; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993.; citation_author=IPM Keet; citation_author=PJ Veugelers; citation_author=M Koot; citation_author=MH de Weerd; citation_author=MTL Roos; citation_journal_title=AIDS; citation_volume=10; citation_number=11; citation_pages=1601-1602; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Is HIV-1 evolving to a less virulent form in humans?; citation_author=KK Arien; citation_author=G Vanham; citation_author=EJ Arts; citation_journal_title=Nat Rev Microbiol; citation_volume=5; citation_number=12; citation_pages=141-151; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.; citation_author=KK Arien; citation_author=RM Troyer; citation_author=Y Gali; citation_author=RL Colebunders; citation_author=EJ Arts; citation_journal_title=Aids; citation_volume=19; citation_number=13; citation_pages=1555-1564; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.; citation_author=Y Gali; citation_author=B Berkhout; citation_author=G Vanham; citation_author=M Bakker; citation_author=NK Back; citation_journal_title=Virology; citation_volume=364; citation_number=14; citation_pages=140-146; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Evolution of mutation rate and virulence among human retroviruses.; citation_author=P Ewald; citation_journal_title=Philos Trans R Soc Lond B Biol Sci; citation_volume=346; citation_number=15; citation_pages=333-341; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection.; citation_author=L Kestens; citation_author=J Vingerhoets; citation_author=M Peeters; citation_author=G Vanham; citation_author=C Vereecken; citation_journal_title=J Infect Dis; citation_volume=172; citation_number=16; citation_pages=957-963; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys.; citation_author=P Fultz; citation_author=T Gordon; citation_author=D Anderson; citation_author=H McClure; citation_journal_title=AIDS; citation_volume=4; citation_number=17; citation_pages=619-625; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.; citation_author=TM Allen; citation_author=M Altfeld; citation_author=XG Yu; citation_author=KM O'Sullivan; citation_author=M Lichterfeld; citation_journal_title=J Virol; citation_volume=78; citation_number=18; citation_pages=7069-7078; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=HIV evolution: CTL escape mutation and reversion after transmission.; citation_author=AJ Leslie; citation_author=KJ Pfafferott; citation_author=P Chetty; citation_author=R Draenert; citation_author=MM Addo; citation_journal_title=Nat Med; citation_volume=10; citation_number=19; citation_pages=282-289; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.; citation_author=PR Harrigan; citation_author=S Bloor; citation_author=BA Larder; citation_journal_title=J Virol; citation_volume=72; citation_number=20; citation_pages=3773-3778; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV.; citation_author=CD Pilcher; citation_author=HC Tien; citation_author=JJ Eron; citation_author=PL Vernazza; citation_author=SY Leu; citation_journal_title=J Infect Dis; citation_volume=189; citation_number=21; citation_pages=1785-1792; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.; citation_author=RH Gray; citation_author=MJ Wawer; citation_author=R Brookmeyer; citation_author=NK Sewankambo; citation_author=D Serwadda; citation_journal_title=Lancet; citation_volume=357; citation_number=22; citation_pages=1149-1153; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.; citation_author=TC Quinn; citation_author=MJ Wawer; citation_author=N Sewankambo; citation_author=D Serwadda; citation_author=C Li; citation_journal_title=N Engl J Med; citation_volume=342; citation_number=23; citation_pages=921-929; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.; citation_author=JW Mellors; citation_author=LA Kingsley; citation_author=CR Rinaldo; citation_author=JA Todd; citation_author=BS Hoo; citation_journal_title=Ann Intern Med; citation_volume=122; citation_number=24; citation_pages=573-579; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.; citation_author=RH Lyles; citation_author=A Munoz; citation_author=TE Yamashita; citation_author=H Bazmi; citation_author=R Detels; citation_journal_title=J Infect Dis; citation_volume=181; citation_number=25; citation_pages=872-880; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell slope for progression to AIDS and death in untreated HIV-1 infection; citation_author=JW Mellors; citation_author=JB Margolick; citation_author=JP Phair; citation_author=CR Rinaldo; citation_author=R Detels; citation_journal_title=Journal of the American Medical Association In Press; citation_number=26; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Estimating the Benefit of an HIV-1 Vaccine That Reduces Viral Load Set Point.; citation_author=SB Gupta; citation_author=LP Jacobson; citation_author=JB Margolick; citation_author=CR Rinaldo; citation_author=JP Phair; citation_journal_title=J Infect Dis; citation_volume=195; citation_number=27; citation_pages=546-550; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Biological and virologic characteristics of primary HIV infection.; citation_author=TW Schacker; citation_author=JP Hughes; citation_author=T Shea; citation_author=RW Coombs; citation_author=L Corey; citation_journal_title=Ann Intern Med; citation_volume=128; citation_number=28; citation_pages=613-620; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.; citation_author=MJ Dolan; citation_author=H Kulkarni; citation_author=JF Camargo; citation_author=W He; citation_author=A Smith; citation_journal_title=Nat Immunol; citation_volume=8; citation_number=29; citation_pages=1324-1336; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.; citation_author=JM Baeten; citation_author=B Chohan; citation_author=L Lavreys; citation_author=V Chohan; citation_author=RS McClelland; citation_journal_title=J Infect Dis; citation_volume=195; citation_number=30; citation_pages=1177-1180; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.; citation_author=RA Kaslow; citation_author=DG Ostrow; citation_author=R Detels; citation_author=JP Phair; citation_author=BF Polk; citation_journal_title=Am J Epidemiol; citation_volume=126; citation_number=31; citation_pages=310-318; citation_date=1987; " />
      <meta name="citation_reference" content="citation_title=Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.; citation_author=JV Giorgi; citation_author=HL Cheng; citation_author=JB Margolick; citation_author=KD Bauer; citation_author=J Ferbas; citation_journal_title=Clin Immunol Immunopathol; citation_volume=55; citation_number=32; citation_pages=173-186; citation_date=1990; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Lack of Evidence for Changing Virulence of HIV-1 in North America"/>
    <meta name="twitter:description" content="BackgroundSeveral long-term cohort studies and in-vitro fitness assays have resulted in inconsistent reports on changes in HIV-1 virulence, including reports of decreasing, stable, and increasing virulence over the course of the AIDS pandemic. We tested the hypothesis of changing HIV-1 virulence by examining trends in prognostic clinical markers of disease progression from 1984 to 2005 among nearly 400 antiretroviral-na&iuml;ve participants in the United States Multicenter AIDS Cohort Study (MACS), a longitudinal study of HIV infection in men who have sex with men (MSM).Methodology/Principal FindingsBecause clinical AIDS endpoints could not be used (due to antiretroviral therapies and prophylaxis), three prognostic markers of disease progression were used as proxies for HIV-1 virulence: plasma viral RNA load and CD4+ T cell count at &ldquo;set point&rdquo; (between &sim;9 and &sim;15 months after seroconversion), and rate of CD4 cell decline within three years after seroconversion. We performed multivariate analyses of the association between these markers and seroconversion year, with covariates including MACS site, race/ethnic group, seroconversion age, and CCR5&Delta;32 status. No statistically significant association was found between year of seroconversion and &ldquo;set point&rdquo; plasma viral load (at &sim;9 months after seroconversion: slope&#8202;=&#8202;&minus;0.004 log10 copies/mL/year, p&#8202;=&#8202;0.76; at &sim;15 months: slope&#8202;=&#8202;&minus;0.005 log10 copies/mL/year, p&#8202;=&#8202;0.71), CD4 cell count after seroconversion (at &sim;9 months: slope&#8202;=&#8202;&minus;0.112 cells/&micro;L/year, p&#8202;=&#8202;0.22; at &sim;15 months: slope&#8202;=&#8202;&minus;0.047 cells/&micro;L/year, p&#8202;=&#8202;0.64), or rate of CD4 cell decline over the first three years after seroconversion (slope&#8202;=&#8202;&minus;0.010 cells/ul/yr2, p&#8202;=&#8202;0.88).Conclusions/SignificanceThe lack of significant trends from 1984 to 2005 in these prognostic markers of HIV disease progression suggests no major change in HIV-1 virulence over the AIDS pandemic in MSM in the US."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001525.g002"/>

  <meta property="og:title" content="Lack of Evidence for Changing Virulence of HIV-1 in North America" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=3105'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=6983'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=2673&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001525">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001525" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001525&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Lack of Evidence for Changing Virulence of HIV-1 in North America
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Joshua T. Herbeck
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Joshua T. Herbeck, Geoffrey S. Gottlieb</p>

              
              

                <p>Affiliation:
                  University of Washington School of Medicine, Seattle, Washington, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Geoffrey S. Gottlieb
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Joshua T. Herbeck, Geoffrey S. Gottlieb</p>

              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:gottlieb@u.washington.edu">gottlieb@u.washington.edu</a></p>

                <p>Affiliation:
                  University of Washington School of Medicine, Seattle, Washington, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Xiuhong Li, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Zheng Hu, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Roger Detels, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  University of California Los Angeles School of Public Health, Los Angeles, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            John Phair, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Northwestern University Medical School, Chicago, Illinois, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Charles Rinaldo, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Lisa P. Jacobson, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Joseph B. Margolick, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            James I. Mullins
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  University of Washington School of Medicine, Seattle, Washington, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: February 06, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001525</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001525-t001" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001525-t002" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001525-t003" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001525-g001" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001525-g002" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001525">Reader Comments (1)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001525" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Several long-term cohort studies and <em>in-vitro</em> fitness assays have resulted in inconsistent reports on changes in HIV-1 virulence, including reports of decreasing, stable, and increasing virulence over the course of the AIDS pandemic. We tested the hypothesis of changing HIV-1 virulence by examining trends in prognostic clinical markers of disease progression from 1984 to 2005 among nearly 400 antiretroviral-naÃ¯ve participants in the United States Multicenter AIDS Cohort Study (MACS), a longitudinal study of HIV infection in men who have sex with men (MSM).</p>


<h3>Methodology/Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>Because clinical AIDS endpoints could not be used (due to antiretroviral therapies and prophylaxis), three prognostic markers of disease progression were used as proxies for HIV-1 virulence: plasma viral RNA load and CD4+ T cell count at âset pointâ (between ~9 and ~15 months after seroconversion), and rate of CD4 cell decline within three years after seroconversion. We performed multivariate analyses of the association between these markers and seroconversion year, with covariates including MACS site, race/ethnic group, seroconversion age, and CCR5Î32 status. No statistically significant association was found between year of seroconversion and âset pointâ plasma viral load (at ~9 months after seroconversion: slope = â0.004 log<sub>10</sub> copies/mL/year, p = 0.76; at ~15 months: slope = â0.005 log<sub>10</sub> copies/mL/year, p = 0.71), CD4 cell count after seroconversion (at ~9 months: slope = â0.112 cells/ÂµL/year, p = 0.22; at ~15 months: slope = â0.047 cells/ÂµL/year, p = 0.64), or rate of CD4 cell decline over the first three years after seroconversion (slope = â0.010 cells/ul/yr<sup>2</sup>, p = 0.88).</p>


<h3>Conclusions/Significance</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>The lack of significant trends from 1984 to 2005 in these prognostic markers of HIV disease progression suggests no major change in HIV-1 virulence over the AIDS pandemic in MSM in the US.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Herbeck JT, Gottlieb GS, Li X, Hu Z, Detels R, et al.  (2008) Lack of Evidence for Changing Virulence of HIV-1 in North America. PLoS ONE 3(2):
          e1525.
            doi:10.1371/journal.pone.0001525</p><p><strong>Academic Editor: </strong>Srikanth Tripathy, National AIDS Research Institute, India</p><p><strong>Received:</strong> September 17, 2007; <strong>Accepted:</strong> January 6, 2008; <strong>Published:</strong> February 6, 2008</p><p><strong>Copyright:</strong> Â© 2008 Herbeck et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>Funding for this study was provided to JIM by R01 AI058894, R37 AI47734, P01 AI57005, to JTH and JIM by P30 AI27757, to JTH by NIH T32 AI07140, STD/HIV Training Grant at University of Washington CFAR, and to GSG by K08 AI049755. The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute. UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Whether HIV-1 has become more or less virulent since its introduction into the human population has significant implications for the course of the AIDS pandemic. Over the last two decades, several studies of long-term cohorts have resulted in conflicting data on this question, including reports of increasing <a href="#pone.0001525-Sinicco1">[1]</a>â<a href="#pone.0001525-Dorrucci2">[4]</a>, stable <a href="#pone.0001525-Holmberg1">[5]</a>â<a href="#pone.0001525-Mller1">[10]</a>, and decreasing virulence <a href="#pone.0001525-Keet1">[11]</a>. There are also contrary reports of changing HIV-1 virulence based on <em>in-vitro</em> competitive viral fitness data used as proxies for virulence. Arien <em>et al</em>. <a href="#pone.0001525-Arien1">[12]</a>, <a href="#pone.0001525-Arien2">[13]</a> found HIV-1 replication capacity was greater in early (1986â1989) than in recent isolates (2002â2003) from Belgium (n = 24), and suggested that HIV may be attenuating over time. In contrast, Gali <em>et al.</em> <a href="#pone.0001525-Gali1">[14]</a>, using the same <em>in-vitro</em> methods in an Amsterdam cohort (n = 25), found that HIV replication capacity was greater in recent (late 1990s) than in earlier isolates (mid-1980s), suggesting the opposite conclusion. In a recent large study of 22 cohorts from Australia, Canada, and Europe, Dorrucci <em>et al</em>. (2007) found trends of decreasing CD4+ T-cell counts (n = 3687) and increasing viral loads (n = 1584) in measurements at ~4 months after seroconversion between 1985 and 2002, suggestive of increasing HIV-1 virulence over time <a href="#pone.0001525-Sinicco1">[1]</a>â<a href="#pone.0001525-Dorrucci2">[4]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Studies of host-pathogen interactions suggest that hosts and pathogens can co-adapt to each other, with pathogens becoming less virulent over time <a href="#pone.0001525-Ewald1">[15]</a>. Possible examples of this phenomenon are primate lentiviruses such as SIVcpz (HIV-1) in chimpanzees and SIVsm (HIV-2) in sooty mangabeys, viruses that cause no apparent disease in their natural hosts <a href="#pone.0001525-Kestens1">[16]</a>, <a href="#pone.0001525-Fultz1">[17]</a>. Attenuation of HIV-1 could result from the decrease in viral fitness that often accompanies viral evolution away from host cytotoxic T-lymphocyte (CTL) and humoral immune responses <a href="#pone.0001525-Allen1">[18]</a>, <a href="#pone.0001525-Leslie1">[19]</a>. In addition, data suggest that the accumulation of drug resistance mutations can reduce the replication capacity of HIV-1 <a href="#pone.0001525-Harrigan1">[20]</a>, which could concomitantly lead to reduced virulence. Conversely, it is also possible that HIV-1 may be under selection for increased virulence in the human population, as higher viral loads are associated with increased probability of transmission <a href="#pone.0001525-Pilcher1">[21]</a>â<a href="#pone.0001525-Quinn1">[23]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Pathogen virulence is most commonly measured in host mortality <a href="#pone.0001525-Ewald1">[15]</a>. For HIV-1, the most direct measure of virulence is the time from initial infection to the development of clinical AIDS and death. Thus, evidence for decreased virulence of HIV-1 would be a lengthening interval from infection to AIDS and death over the course of the epidemic. We tested the hypothesis of changing HIV-1 virulence by examining trends in rate of progression of HIV-1 infection in men followed in the Multicenter AIDS Cohort Study (MACS) from 1984 to 2005. Prognostic markers of disease progression had to be used as endpoints, because direct measures of this rate, such as time from seroconversion to AIDS and death, have been dramatically affected over the second half of this interval by the advent of potent antiretroviral therapies and by progress in prophylaxis and treatment of opportunistic infections and AIDS-related malignancies. Of the multiple prognostic markers of HIV-1 disease progression, we selected 1) the viral set point, defined as the plasma viral RNA level at the second or third semiannual visit after seroconversion, because it has been shown to be the strongest single early predictor of disease course <a href="#pone.0001525-Mellors1">[24]</a>â<a href="#pone.0001525-Gupta1">[27]</a>, and 2) the CD4 cell count and the slope of its decline, because these markers have commonly been used in cohort-based analyses of long-term changes in HIV virulence <a href="#pone.0001525-Sinicco1">[1]</a>, <a href="#pone.0001525-Dorrucci1">[3]</a>, <a href="#pone.0001525-OBrien1">[6]</a>, <a href="#pone.0001525-Galai1">[7]</a>.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3><a id="article1.body1.sec2.p1" name="article1.body1.sec2.p1"></a><p>The demographic characteristics of the study population are shown in <a href="#pone-0001525-t001">Table 1</a>. The median plasma viral load at the second seropositive visit (~9 months after seroconversion) was 4.485 log<sub>10</sub> copies/mL (n = 357); at the third seropositive visit (~15 months) this figure was 4.399 log<sub>10</sub> copies/mL (n = 318) (<a href="#pone-0001525-t001">Table 1</a>). The median CD4 cell count was 624 cells/ÂµL (n = 375) at the second visit and 588 cells/ÂµL (n = 348) at the third visit (<a href="#pone-0001525-t001">Table 1</a>).</p>
<div class="figure" id="pone-0001525-t001"><div class="img"><a name="pone-0001525-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001525.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001525.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Summary of participants and data.</span></strong></p><span>doi:10.1371/journal.pone.0001525.t001</span></div><a id="article1.body1.sec2.p2" name="article1.body1.sec2.p2"></a><p>We found no significant trends in set point plasma viral load over the 20-year study period, in either univariate or multivariate models. For the viral load at the second seropositive visit, the slope was â0.004 log<sub>10</sub> copies/mL/year, (p = 0.76; <a href="#pone-0001525-t002">Table 2</a>); for the third seropositive visit the slope was â0.005 log<sub>10</sub> copies/mL/year (p = 0.71; <a href="#pone-0001525-t002">Table 2</a>). Among the covariates examined in the multivariate model, only heterozygosity of the coreceptor allele CCR5Î32 showed a significant association with viral setpoint (<a href="#pone-0001525-t002">Table 2</a>) (no participant was CCR5Î32 homozygous).</p>
<div class="figure" id="pone-0001525-t002"><div class="img"><a name="pone-0001525-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001525.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001525.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Multivariate analyses of prognostic markers of HIV-1 disease.</span></strong></p><span>doi:10.1371/journal.pone.0001525.t002</span></div><a id="article1.body1.sec2.p3" name="article1.body1.sec2.p3"></a><p>In the CD4 cell count analysis, we found no significant association between calendar year of seroconversion and the square root-transformed CD4 cell count at either the second or third seropositive visits, in either univariate or multivariate analysis. Specifically, the slope of the square root-transformed CD4 cell count at the second seropositive visit was â0.112 cells/ÂµL/year (p = 0.22; <a href="#pone-0001525-t002">Table 2</a>); and at the third seropositive visit this slope was â0.047 cells/ÂµL/year (p = 0.64; <a href="#pone-0001525-t002">Table 2</a>). Similarly, there was no correlation between calendar year of seroconversion and rate of CD4 cell decline over the first three years after seroconversion, in either univariate or multivariate models (slope = â0.010 cells/ul/yr<sup>2</sup>, p = 0.88; <a href="#pone-0001525-t003">Table 3</a>). None of the covariates examined was significantly associated with either the CD4 cell count at the second or third seropositive visit, or its slope over the first three years after seroconversion (<a href="#pone-0001525-t002">Table 2</a>, <a href="#pone-0001525-t003">Table 3</a>).</p>
<div class="figure" id="pone-0001525-t003"><div class="img"><a name="pone-0001525-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001525.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001525.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Multivariate analyses of prognostic markers of HIV-1 disease.</span></strong></p><span>doi:10.1371/journal.pone.0001525.t003</span></div><a id="article1.body1.sec2.p4" name="article1.body1.sec2.p4"></a><p>In the analysis of the mean of the second and third seropositive visits (if data was available for both visits, only one visit if only visit had data available), we found no significant temporal trend in viral load (n = 384, slope = â0.005 log<sub>10</sub> copies/mL/year, p = 0.66) (<a href="#pone-0001525-t003">Table 3</a>) (<a href="#pone-0001525-g001">Figure 1</a>). We found a slight decreasing trend in square-root transformed CD4 cell count (n = 409, slope = â0.138 cells/ÂµL/year, p = 0.10) (<a href="#pone-0001525-t003">Table 3</a>) (<a href="#pone-0001525-g002">Figure 2</a>). These trends translate to decreases of of ~0.1 log<sub>10</sub> copies/mL in viral load set point and ~7 cells for the CD4 cell count over the 20 year study period; neither of these values is clinically significant.</p>
<div class="figure" id="pone-0001525-g001"><div class="img"><a name="pone-0001525-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001525.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001525.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>RNA viral loads through time.</span></strong></p><a id="article1.body1.sec2.fig1.caption1.p1" name="article1.body1.sec2.fig1.caption1.p1"></a><p>A) Boxplot for the mean of log10 HIV RNA at second and third seropositive visits (~9 and ~15 months after estimated date of seroconversion) by calendar period of seroconversion. The horizontal line in the interior of the box denotes the median; and the height of the box is equal to the interquartile distance (IQD). The whiskers (the dotted lines extending from the top and bottom of the box) extend to the extreme values of the data or a distance 1.5ÃIQD from the center, whichever is less. The horizontal lines falling outside the whiskers represent outliers. B) Relationship between the mean of log10 HIV RNA at second and third seropositive visits and calendar year of seroconversion. Three solid lines are the fitted regression line and its 95% confidence bands from univariate linear regression (note that slope estimates reported in manuscript text are from multivariate analysis).</p>
<span>doi:10.1371/journal.pone.0001525.g001</span></div><div class="figure" id="pone-0001525-g002"><div class="img"><a name="pone-0001525-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001525" data-uri="info:doi/10.1371/journal.pone.0001525.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001525.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001525.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001525.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001525.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001525.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>CD4+ T cell levels through time.</span></strong></p><a id="article1.body1.sec2.fig2.caption1.p1" name="article1.body1.sec2.fig2.caption1.p1"></a><p>A) Boxplot for the mean of square-root transformed CD4+ T-cell count at second and third seropositive visits (~9 and ~15 months after estimated date of seroconversion) by calendar period of seroconversion. Boxes are defined as in the legend to <a href="#pone-0001525-g001">Figure 1</a>. B) Relationship between the mean of square-root transformed CD4+ T-cell count at second and third seropositive visits and calendar year of seroconversion. Three solid lines are the fitted regression line and its 95% confidence bands from univariate linear regression (note that slope estimates reported in manuscript text are from multivariate analysis).</p>
<span>doi:10.1371/journal.pone.0001525.g002</span></div><a id="article1.body1.sec2.p5" name="article1.body1.sec2.p5"></a><p>All of the above analyses were also done using calendar years in bins comprised of data from 5 year intervals, and yielded results consistent with the above analyses of individual calendar years. We also tested for a trend over time in the lag between estimated date of seroconversion and the second and third seropositive visits; no trend was found.</p>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>We tested for associations between calendar year of seroconversion and three prognostic markers of disease progression in the MACS cohort between 1984 and 2005. Our results showed no significant trends in set point plasma viral RNA load, CD4 cell count after seroconversion, or the rate of CD4 cell decline in the first three years after seroconversion. Moreover, estimates of change in these markers over time were very close to zero. Thus, the results of this study do not support the hypothesis that there has been any important change in the virulence of HIV-1 over this time period in this cohort. This is consistent with recent findings that revealed no long-term changes in virulence over 20 years in a Swiss cohort <a href="#pone.0001525-Mller1">[10]</a>, and with a previous analysis of MACS participants that reported stable rates of CD4 cell loss between 1984 and 1991 <a href="#pone.0001525-OBrien1">[6]</a>.</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>Our results are contrary to those from studies of long-term cohorts have found decreasing <a href="#pone.0001525-Keet1">[11]</a> or increasing <a href="#pone.0001525-Sinicco1">[1]</a>â<a href="#pone.0001525-Dorrucci2">[4]</a> virulence over time. The largest study to date, by Dorrucci <em>et al</em>. <a href="#pone.0001525-Dorrucci2">[4]</a>, analyzed Australian, Canadian, and European cohorts from 1985 to 2002, and found a decreasing trend in the first CD4 cell count (n = 3687) and an increasing trend in the first viral load (n = 1584) after seroconversion. That study used the first CD4 cell count after seroconversion, with a median lag time between seroconversion and CD4 cell count of ~4 months; we used CD4 cell counts at ~9 and ~15 months after seroconversion. In order to more directly compare our and Dorrucci <em>et al.</em>'s results, we estimated trends from 1984 to 2005 in the plasma viral load and CD4 cell count at the first seropositive visit in the MACS cohort, corresponding to ~3 months after seroconversion. We again found no significant association between viral load and seroconversion year (n = 375, slope = â0.011 log<sub>10</sub> copies/mL/year, p = 0.48, 95% CI â0.042 to 0.020), but did observe a decreasing trend in square-root transformed CD4 cell count (n = 408, slope = â0.194 cells/ÂµL/year, p = 0.03, 95% CI â0.363 to â0.024). We suspect this result, and the discrepancy between our analyses at ~9 and ~15 months after seroconversion and those of Dorrucci <em>et al</em>., may be due to the significant CD4 cell fluctuations that occur during acute and early infections <a href="#pone.0001525-Lyles1">[25]</a>, <a href="#pone.0001525-Schacker1">[28]</a>. By ~9 and ~15 months after seroconversion CD4 cell counts have likely recovered and stabilized from these fluctuations. It will be beneficial to examine trends in viral load and CD4 cell count at later timepoints after seroconversion in the Dorrucci <em>et al.</em> cohorts.</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>Our results are also contrary to the recent inference of HIV-1 attenuation based on <em>in-vitro</em> competitive fitness data between early (1986â1989) and recent isolates (2002â2003) from Belgium <a href="#pone.0001525-Arien1">[12]</a>, <a href="#pone.0001525-Arien2">[13]</a>. However, Gali <em>et al</em>. <a href="#pone.0001525-Gali1">[14]</a> used the same fitness assay approach in a study comparing Amsterdam Cohort Studies samples from the mid-1980s against samples from the late 1990s, matched for time since seroconversion, coreceptor usage, and viral subtype. They found that the recent isolates had higher fitness than earlier isolates, and suggested HIV-1 virulence may be increasing in this cohort. The number of isolates tested in these two studies was small (n = 24 and 25, respectively). As hinted at by these discrepant results, it is possible that changes in <em>in-vitro</em> fitness are not directly or easily compared to clinical prognostic markers or virulence in humans, and that larger sample sizes may be required in these assays.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>Host factors (and potentially other unknown factors) can affect rates of disease progression independently of viral load <a href="#pone.0001525-Dolan1">[29]</a>; it is possible that existing variation in progression rates to AIDS or death in the MACS is not reflected in the viral load or CD4 cell count data we examined. However, it is unlikely that allele frequencies of particular host factors (<em>e.g.</em> CCR5Î32, CCL3L1) have changed significantly in humans between 1984â2005. HIV-1 subtypes can vary in disease progression rates independently from viral load as well <a href="#pone.0001525-Baeten1">[30]</a>. Yet we believe that all, or at least the vast majority, of the subjects in this study are infected with subtype B, as there have been no reports of non-subtype B virus in the MACS to this date.</p>
<a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5"></a><p>Our study has some limitations. First, seroconverters in the MACS cohort were significantly more frequent in the first decade of the study period than in later years. Second, even though the MACS followed large numbers of seroconverters until clinical AIDS or death, we were unable to use those disease outcomes in our analyses because calendar year is linked to progress in HIV/AIDS disease management (<em>e.g</em>., prophylaxis and treatment of opportunistic infections, and development of more potent antiretroviral therapies). Thus, we had to rely on prognostic markers to study trends in HIV-1 disease progression rates. Third, because we excluded men who started antiretroviral therapy, there is a possible selection bias; men who experienced disease progression would not contribute to our analysis, and any decrease of the mean time from seroconversion to first therapy (into the second or third seropositive visit) over the study period would not be detected. However, the number of men excluded is small (for viral load analysis, n = 5 at first seropositive visit, n = 14 at second, n = 16 at third; for CD4 analysis, n = 6 at first seropositive visit, n = 20 at second, n = 18 at third; for CD4 slope analysis, n = 28 in the first three years after seroconversion), and this likely did not impact our analyses. Fourth, we could not correct for the changes in laboratory methods for CD4 or viral load measurements over this time period, as the these changes correlate completely with year (and we are looking for changes in estimates of these markers by year). This issue is one that plagues all similar studies, including Dorrucci <em>et al.</em> (2007). Lastly, although we found no significant changes in set point viral load over the 20 years of observation, the 95% confidence intervals encompass a range of ~â0.6 to +0.4 log<sub>10</sub> copies/mL over this period (<a href="#pone-0001525-t002">Table 2</a>), which is greater than the 0.3 log<sub>10</sub> copies/mL cut-off that has been used as a âclinically significantâ change in this marker <a href="#pone.0001525-Mellors1">[24]</a>, <a href="#pone.0001525-Lyles1">[25]</a>.</p>
<a id="article1.body1.sec3.p6" name="article1.body1.sec3.p6"></a><p>In conclusion, our data suggest that there has been no change in HIV-1 virulence over the last 20 years in the MACS cohort. However, it is unclear if more frequent and earlier use of highly active antiretroviral therapy will have an eventual negative impact on transmission and subsequent HIV virulence, or if the association between higher viral loads and transmission risk will eventually select for greater virulence in the human population.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Study population</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>The Multicenter AIDS Cohort Study (MACS) is an ongoing prospective study of the natural and treated histories of HIV-1 infection in homosexual and bisexual men conducted by sites located in Baltimore, Chicago, Pittsburgh and Los Angeles <a href="#pone.0001525-Kaslow1">[31]</a>. A total of 6,972 men have been enrolled during three enrollment periods: April 1984 through March 1985 (n = 4954), April 1987 through September 1991 (N = 668), and October 2001 and August 2003 (n = 1350). MACS participants were seen during semi-annual visits at one of the study sites where they underwent standardized questionnaires, physical examinations and laboratory assessments <a href="#pone.0001525-Kaslow1">[31]</a>. Study participants in the MACS provided written informed consent and IRB approval for this study was obtained from the University of Washington and the MACS parent institutions.</p>
<a id="article1.body1.sec4.sec1.p2" name="article1.body1.sec4.sec1.p2"></a><p>At the time of the present analysis, there were 2884 men who had entered the study as HIV-seroprevalent, and 596 men with a known date of seroconversion. Estimated date of seroconversion was the median time between the last seronegative visit and the first seropositive visit. For each participant, we included only data from visits prior to the start of any antiretroviral treatment (including any mono-, dual-, or highly active antiretroviral therapy (ART)). We further restricted the analysis to those 483 seroconverters who had less than one year between their last seronegative and first seropositive visits. Of these, 357 had plasma viral load measurements at ~9 months after estimated date of seroconversion, and 318 had viral load measurements at ~15 months after seroconversion date. The corresponding numbers for CD4 cell counts were 375 and 348, respectively (<a href="#pone-0001525-t001">Table 1</a>). To increase the sample sizes in our analyses, we also tested for associations between prognostic markers and year of seroconversion using combined data from the second and third seropositive visits. The mean of the two visits was used if data was available for both visits; if data from only one of these visits was available, that value was used. This approach increased overall numbers included to 384 for plasma viral load and 409 for CD4 cell count, and also reduced potential lag-time or outlier bias.</p>
<a id="article1.body1.sec4.sec1.p3" name="article1.body1.sec4.sec1.p3"></a><p>The 596 men with known dates of seroconversion included 59 men from Pittsburgh who enrolled in the MACS already seroprevalent but with a known seroconversion date; 49 of these men had less than one year between their last seronegative and first seropositive visits, and 11 of these had viral load and CD4 measurements within 6 to 18 months of seroconversion. For our tests of seroconversion year versus rate (slope) of CD4 cell decline, 412 men contributed at least two measurements within three years following seroconversion and had no missing information on race, age, and CCR5Î32 genotype, and thus contributed to the multivariate analysis.</p>


<h4>Laboratory Methods</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>At each semiannual MACS visit, absolute CD4+ T lymphocyte counts were obtained by flow cytometry <a href="#pone.0001525-Giorgi1">[32]</a> and an automated complete blood count and differential determined. HIV-1 RNA was measured in stored plasma samples by reverse-transcription polymerase chain reaction (RT-PCR) (AMPLICOR HIV-1 MONITOR Test, Roche Diagnostics, Nutley, NJ) with assay detection limits of 400 (Standard Assay) and 50 (UltraSensitive Assay) copies/mL.</p>


<h4>Statistical Analysis</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>We performed univariate and multivariate linear regression of the association between date of seroconversion (independent) and prognostic markers of HIV infection (dependent): 1) plasma viral load (log<sub>10</sub> copies/mL) at the second (~9 months) and third (~15 months) seropositive visits; 2) the CD4 cell count (square root-transformed to achieve approximate normality) at the second and third seropositive visits; and 3) slope of the CD4 cell decline per year within three years after seroconversion. Covariates included MACS center location (Baltimore, Chicago, Los Angeles, Pittsburgh), race (Black non-Hispanic, Hispanic, White non-Hispanic, and other), age at seroconversion (centered at 30 years old), and CCR5 gene status (homozygous wild type vs. heterozygous Î32). Statistical associations were performed using SAS 9.1 (SAS institute, Cary NC). Graphs for figures were generated using S-Plus 6.2 (Insightful Corporation, Seattle, WA).</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS) with centers (Principal Investigators) at The Johns Hopkins University Bloomberg School of Public Health (Joseph B. Margolick, Lisa Jacobson), Howard Brown Health Center and Northwestern University Medical School (John Phair), University of California, Los Angeles (Roger Detels), and University of Pittsburgh (Charles Rinaldo). Website located at <a href="http://www.statepi.jhsph.edu/macs/macs.html">http://www.statepi.jhsph.edu/macs/macs.hâtml</a>.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: GG JH. Analyzed the data: LJ GG JH JM. Contributed reagents/materials/analysis tools: JM CR LJ JP RD ZH XL JM. Wrote the paper: GG JH. Other: Helped write the paper: JIM JBM. Performed statistical analysis: ZH XL.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001525-Sinicco1" id="pone.0001525-Sinicco1"></a>Sinicco A, Fora R, Raiteri R, Sciandra M, Bechis G, et al.  (1997) Is the clinical course of HIV-1 changing? Cohort study. British Medical Journal  315: 1232â1237.  <ul class="find" data-citedArticleID="1049128" data-doi="10.1136/bmj.314.7089.1232"><li><a href="http://dx.doi.org/10.1136/bmj.314.7089.1232" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Is+the+clinical+course+of+HIV-1+changing%3F+Cohort+study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Is+the+clinical+course+of+HIV-1+changing%3F+Cohort+study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001525-Vanhems1" id="pone.0001525-Vanhems1"></a>Vanhems P, Lambert J, Guerra M, Hirschel B, Allard R (1999) Association between the Rate of CD4+ T Cell Decrease and the Year of Human Immunodeficiency Virus (HIV) Type 1 Seroconversion among Persons Enrolled in the Swiss HIV Cohort Study. J Infect Dis  180: 1803â1808.  <ul class="find" data-citedArticleID="1049130" data-doi="10.1086/315110"><li><a href="http://dx.doi.org/10.1086/315110" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+between+the+Rate+of+CD4%2B+T+Cell+Decrease+and+the+Year+of+Human+Immunodeficiency+Virus+%28HIV%29+Type+1+Seroconversion+among+Persons+Enrolled+in+the+Swiss+HIV+Cohort+Study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+between+the+Rate+of+CD4%2B+T+Cell+Decrease+and+the+Year+of+Human+Immunodeficiency+Virus+%28HIV%29+Type+1+Seroconversion+among+Persons+Enrolled+in+the+Swiss+HIV+Cohort+Study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001525-Dorrucci1" id="pone.0001525-Dorrucci1"></a>Dorrucci M, Phillips A, Longo B, Rezza G (2005) Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. AIDS  19: 331â335.  <ul class="find" data-citedArticleID="1049082"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Changes+over+time+in+post-seroconversion+CD4+cell+counts+in+the+Italian+HIV-Seroconversion+Study%3A+1985-2002.&amp;auth=&amp;atitle=Changes+over+time+in+post-seroconversion+CD4+cell+counts+in+the+Italian+HIV-Seroconversion+Study%3A+1985-2002." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Changes+over+time+in+post-seroconversion+CD4+cell+counts+in+the+Italian+HIV-Seroconversion+Study%3A+1985-2002." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Changes+over+time+in+post-seroconversion+CD4+cell+counts+in+the+Italian+HIV-Seroconversion+Study%3A+1985-2002.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001525-Dorrucci2" id="pone.0001525-Dorrucci2"></a>Dorrucci M, Rezza G, Porter K, Phillips A (2007) Temporal Trends in Postseroconversion CD4 Cell Count and HIV Load: The Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. J Infect Dis  195: 525â534.  <ul class="find" data-citedArticleID="1049084" data-doi="10.1086/510911"><li><a href="http://dx.doi.org/10.1086/510911" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Temporal+Trends+in+Postseroconversion+CD4+Cell+Count+and+HIV+Load%3A+The+Concerted+Action+on+Seroconversion+to+AIDS+and+Death+in+Europe+Collaboration%2C+1985-2002." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Temporal+Trends+in+Postseroconversion+CD4+Cell+Count+and+HIV+Load%3A+The+Concerted+Action+on+Seroconversion+to+AIDS+and+Death+in+Europe+Collaboration%2C+1985-2002.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001525-Holmberg1" id="pone.0001525-Holmberg1"></a>Holmberg S, Conley L, Luby S, Cohn S, Wong L, et al.  (1995) Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol  9: 291â296.  <ul class="find" data-citedArticleID="1049102" data-doi="10.1097/00042560-199507000-00011"><li><a href="http://dx.doi.org/10.1097/00042560-199507000-00011" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Recent+infection+with+human+immunodeficiency+virus+and+possible+rapid+loss+of+CD4+T+lymphocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Recent+infection+with+human+immunodeficiency+virus+and+possible+rapid+loss+of+CD4+T+lymphocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001525-OBrien1" id="pone.0001525-OBrien1"></a>O'Brien T, Hoover D, Rosenberg P, Chen B, Detels R, et al.  (1995) Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. Am J Epidemiol  142: 636â642.  <ul class="find" data-citedArticleID="1049120"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Evaluation+of+secular+trends+in+CD4%2B+lymphocyte+loss+among+human+immunodeficiency+virus+type+1+%28HIV-1%29-infected+men+with+known+dates+of+seroconversion.&amp;auth=&amp;atitle=Evaluation+of+secular+trends+in+CD4%2B+lymphocyte+loss+among+human+immunodeficiency+virus+type+1+%28HIV-1%29-infected+men+with+known+dates+of+seroconversion." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Evaluation+of+secular+trends+in+CD4%2B+lymphocyte+loss+among+human+immunodeficiency+virus+type+1+%28HIV-1%29-infected+men+with+known+dates+of+seroconversion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Evaluation+of+secular+trends+in+CD4%2B+lymphocyte+loss+among+human+immunodeficiency+virus+type+1+%28HIV-1%29-infected+men+with+known+dates+of+seroconversion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001525-Galai1" id="pone.0001525-Galai1"></a>Galai N, Lepri A, Viahov D, Pezzotti P, Sinicco A, et al.  (1996) Temporal trends of initial CD4 cells counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol  143: 278â282.  <ul class="find" data-citedArticleID="1049090" data-doi="10.1093/oxfordjournals.aje.a008739"><li><a href="http://dx.doi.org/10.1093/oxfordjournals.aje.a008739" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Temporal+trends+of+initial+CD4+cells+counts+following+human+immunodeficiency+virus+seroconversion+in+Italy%2C+1985-1992.+The+Human+Immunodeficiency+Virus+Italian+Seroconversion+Study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Temporal+trends+of+initial+CD4+cells+counts+following+human+immunodeficiency+virus+seroconversion+in+Italy%2C+1985-1992.+The+Human+Immunodeficiency+Virus+Italian+Seroconversion+Study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001525-CASCADE1" id="pone.0001525-CASCADE1"></a>CASCADE (2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active anti-retroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on Seroconversion to AIDS and Death in Europe. Lancet  355: 1131â1137.  <ul class="find" data-citedArticleID="1049076" data-doi="10.1016/s0140-6736(00)02061-4"><li><a href="http://dx.doi.org/10.1016/s0140-6736(00)02061-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Time+from+HIV-1+seroconversion+to+AIDS+and+death+before+widespread+use+of+highly-active+anti-retroviral+therapy%3A+a+collaborative+re-analysis.+Collaborative+Group+on+AIDS+Incubation+and+HIV+Survival+including+the+CASCADE+EU+Concerted+Action.+Concerted+Action+on+Seroconversion+to+AIDS+and+Death+in+Europe." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Time+from+HIV-1+seroconversion+to+AIDS+and+death+before+widespread+use+of+highly-active+anti-retroviral+therapy%3A+a+collaborative+re-analysis.+Collaborative+Group+on+AIDS+Incubation+and+HIV+Survival+including+the+CASCADE+EU+Concerted+Action.+Concerted+Action+on+Seroconversion+to+AIDS+and+Death+in+Europe.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001525-CASCADE2" id="pone.0001525-CASCADE2"></a>CASCADE (2003) Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr  34: 76â83.  <ul class="find" data-citedArticleID="1049078" data-doi="10.1097/00126334-200309010-00012"><li><a href="http://dx.doi.org/10.1097/00126334-200309010-00012" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differences+in+CD4+cell+counts+at+seroconversion+and+decline+among+5739+HIV-1-infected+individuals+with+well-estimated+dates+of+seroconversion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differences+in+CD4+cell+counts+at+seroconversion+and+decline+among+5739+HIV-1-infected+individuals+with+well-estimated+dates+of+seroconversion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001525-Mller1" id="pone.0001525-Mller1"></a>MÃ¼ller V, Ledergerber B, Perrin L, Klimkait T, Furrer H, et al.  (2006) Stable virulence levels in the HIV epidemic of Switzerland over two decades. Aids  20: 889â894.  <ul class="find" data-citedArticleID="1049118" data-doi="10.1097/01.aids.0000218553.51908.6b"><li><a href="http://dx.doi.org/10.1097/01.aids.0000218553.51908.6b" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Stable+virulence+levels+in+the+HIV+epidemic+of+Switzerland+over+two+decades." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Stable+virulence+levels+in+the+HIV+epidemic+of+Switzerland+over+two+decades.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001525-Keet1" id="pone.0001525-Keet1"></a>Keet IPM, Veugelers PJ, Koot M, de Weerd MH, Roos MTL, et al.  (1996) Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. AIDS  10: 1601â1602.  <ul class="find" data-citedArticleID="1049106" data-doi="10.1097/00002030-199611000-00025"><li><a href="http://dx.doi.org/10.1097/00002030-199611000-00025" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Temporal+trends+of+the+natural+history+of+HIV-1+infection+following+seroconversion+between+1984+and+1993." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Temporal+trends+of+the+natural+history+of+HIV-1+infection+following+seroconversion+between+1984+and+1993.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001525-Arien1" id="pone.0001525-Arien1"></a>Arien KK, Vanham G, Arts EJ (2007) Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol  5: 141â151.  <ul class="find" data-citedArticleID="1049070" data-doi="10.1038/nrmicro1594"><li><a href="http://dx.doi.org/10.1038/nrmicro1594" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Is+HIV-1+evolving+to+a+less+virulent+form+in+humans%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Is+HIV-1+evolving+to+a+less+virulent+form+in+humans%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001525-Arien2" id="pone.0001525-Arien2"></a>Arien KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, et al.  (2005) Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. Aids  19: 1555â1564.  <ul class="find" data-citedArticleID="1049072" data-doi="10.1097/01.aids.0000185989.16477.91"><li><a href="http://dx.doi.org/10.1097/01.aids.0000185989.16477.91" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Replicative+fitness+of+historical+and+recent+HIV-1+isolates+suggests+HIV-1+attenuation+over+time." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Replicative+fitness+of+historical+and+recent+HIV-1+isolates+suggests+HIV-1+attenuation+over+time.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001525-Gali1" id="pone.0001525-Gali1"></a>Gali Y, Berkhout B, Vanham G, Bakker M, Back NK, et al.  (2007) Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort. Virology  364: 140â146.  <ul class="find" data-citedArticleID="1049092" data-doi="10.1016/j.virol.2007.02.021"><li><a href="http://dx.doi.org/10.1016/j.virol.2007.02.021" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Survey+of+the+temporal+changes+in+HIV-1+replicative+fitness+in+the+Amsterdam+Cohort." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Survey+of+the+temporal+changes+in+HIV-1+replicative+fitness+in+the+Amsterdam+Cohort.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001525-Ewald1" id="pone.0001525-Ewald1"></a>Ewald P (1994) Evolution of mutation rate and virulence among human retroviruses. Philos Trans R Soc Lond B Biol Sci  346: 333â341.  <ul class="find" data-citedArticleID="1049086"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Evolution+of+mutation+rate+and+virulence+among+human+retroviruses.&amp;auth=&amp;atitle=Evolution+of+mutation+rate+and+virulence+among+human+retroviruses." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Evolution+of+mutation+rate+and+virulence+among+human+retroviruses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Evolution+of+mutation+rate+and+virulence+among+human+retroviruses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001525-Kestens1" id="pone.0001525-Kestens1"></a>Kestens L, Vingerhoets J, Peeters M, Vanham G, Vereecken C, et al.  (1995) Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis  172: 957â963.  <ul class="find" data-citedArticleID="1049108" data-doi="10.1093/infdis/172.4.957"><li><a href="http://dx.doi.org/10.1093/infdis/172.4.957" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Phenotypic+and+functional+parameters+of+cellular+immunity+in+a+chimpanzee+with+a+naturally+acquired+simian+immunodeficiency+virus+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Phenotypic+and+functional+parameters+of+cellular+immunity+in+a+chimpanzee+with+a+naturally+acquired+simian+immunodeficiency+virus+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001525-Fultz1" id="pone.0001525-Fultz1"></a>Fultz P, Gordon T, Anderson D, McClure H (1990) Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS  4: 619â625.  <ul class="find" data-citedArticleID="1049088" data-doi="10.1097/00002030-199007000-00002"><li><a href="http://dx.doi.org/10.1097/00002030-199007000-00002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prevalence+of+natural+infection+with+simian+immunodeficiency+virus+and+simian+T-cell+leukemia+virus+type+I+in+a+breeding+colony+of+sooty+mangabey+monkeys." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prevalence+of+natural+infection+with+simian+immunodeficiency+virus+and+simian+T-cell+leukemia+virus+type+I+in+a+breeding+colony+of+sooty+mangabey+monkeys.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001525-Allen1" id="pone.0001525-Allen1"></a>Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, et al.  (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol  78: 7069â7078.  <ul class="find" data-citedArticleID="1049068" data-doi="10.1128/jvi.78.13.7069-7078.2004"><li><a href="http://dx.doi.org/10.1128/jvi.78.13.7069-7078.2004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Selection%2C+transmission%2C+and+reversion+of+an+antigen-processing+cytotoxic+T-lymphocyte+escape+mutation+in+human+immunodeficiency+virus+type+1+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Selection%2C+transmission%2C+and+reversion+of+an+antigen-processing+cytotoxic+T-lymphocyte+escape+mutation+in+human+immunodeficiency+virus+type+1+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001525-Leslie1" id="pone.0001525-Leslie1"></a>Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al.  (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med  10: 282â289.  <ul class="find" data-citedArticleID="1049110" data-doi="10.1038/nm992"><li><a href="http://dx.doi.org/10.1038/nm992" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HIV+evolution%3A+CTL+escape+mutation+and+reversion+after+transmission." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HIV+evolution%3A+CTL+escape+mutation+and+reversion+after+transmission.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001525-Harrigan1" id="pone.0001525-Harrigan1"></a>Harrigan PR, Bloor S, Larder BA (1998) Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates <em>in vitro</em>. J Virol  72: 3773â3778.  <ul class="find" data-citedArticleID="1049100"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Relative+replicative+fitness+of+zidovudine-resistant+human+immunodeficiency+virus+type+1+isolates+in+vitro.&amp;auth=&amp;atitle=Relative+replicative+fitness+of+zidovudine-resistant+human+immunodeficiency+virus+type+1+isolates+in+vitro." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Relative+replicative+fitness+of+zidovudine-resistant+human+immunodeficiency+virus+type+1+isolates+in+vitro." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Relative+replicative+fitness+of+zidovudine-resistant+human+immunodeficiency+virus+type+1+isolates+in+vitro.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001525-Pilcher1" id="pone.0001525-Pilcher1"></a>Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, et al.  (2004) Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV. J Infect Dis  189: 1785â1792.  <ul class="find" data-citedArticleID="1049122" data-doi="10.1086/386333"><li><a href="http://dx.doi.org/10.1086/386333" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Brief+but+Efficient%3A+Acute+HIV+Infection+and+the+Sexual+Transmission+of+HIV." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Brief+but+Efficient%3A+Acute+HIV+Infection+and+the+Sexual+Transmission+of+HIV.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001525-Gray1" id="pone.0001525-Gray1"></a>Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al.  (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet  357: 1149â1153.  <ul class="find" data-citedArticleID="1049096" data-doi="10.1016/s0140-6736(00)04331-2"><li><a href="http://dx.doi.org/10.1016/s0140-6736(00)04331-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Probability+of+HIV-1+transmission+per+coital+act+in+monogamous%2C+heterosexual%2C+HIV-1-discordant+couples+in+Rakai%2C+Uganda." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Probability+of+HIV-1+transmission+per+coital+act+in+monogamous%2C+heterosexual%2C+HIV-1-discordant+couples+in+Rakai%2C+Uganda.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001525-Quinn1" id="pone.0001525-Quinn1"></a>Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al.  (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med  342: 921â929.  <ul class="find" data-citedArticleID="1049124" data-doi="10.1056/nejm200003303421303"><li><a href="http://dx.doi.org/10.1056/nejm200003303421303" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Viral+load+and+heterosexual+transmission+of+human+immunodeficiency+virus+type+1.+Rakai+Project+Study+Group." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Viral+load+and+heterosexual+transmission+of+human+immunodeficiency+virus+type+1.+Rakai+Project+Study+Group.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001525-Mellors1" id="pone.0001525-Mellors1"></a>Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, et al.  (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med  122: 573â579.  <ul class="find" data-citedArticleID="1049114" data-doi="10.7326/0003-4819-122-8-199504150-00003"><li><a href="http://dx.doi.org/10.7326/0003-4819-122-8-199504150-00003" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Quantitation+of+HIV-1+RNA+in+plasma+predicts+outcome+after+seroconversion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Quantitation+of+HIV-1+RNA+in+plasma+predicts+outcome+after+seroconversion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001525-Lyles1" id="pone.0001525-Lyles1"></a>Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, et al.  (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis  181: 872â880.  <ul class="find" data-citedArticleID="1049112" data-doi="10.1086/315339"><li><a href="http://dx.doi.org/10.1086/315339" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Natural+history+of+human+immunodeficiency+virus+type+1+viremia+after+seroconversion+and+proximal+to+AIDS+in+a+large+cohort+of+homosexual+men.+Multicenter+AIDS+Cohort+Study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Natural+history+of+human+immunodeficiency+virus+type+1+viremia+after+seroconversion+and+proximal+to+AIDS+in+a+large+cohort+of+homosexual+men.+Multicenter+AIDS+Cohort+Study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001525-Mellors2" id="pone.0001525-Mellors2"></a>Mellors JW, Margolick JB, Phair JP, Rinaldo CR, Detels R, et al.  (2007) Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell slope for progression to AIDS and death in untreated HIV-1 infection Journal of the American Medical Association In Press.   <ul class="find" data-citedArticleID="1049116" data-doi="10.1001/jama.297.21.2349"><li><a href="http://dx.doi.org/10.1001/jama.297.21.2349" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prognostic+value+of+HIV-1+RNA%2C+CD4+cell+count%2C+and+CD4+cell+slope+for+progression+to+AIDS+and+death+in+untreated+HIV-1+infection" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prognostic+value+of+HIV-1+RNA%2C+CD4+cell+count%2C+and+CD4+cell+slope+for+progression+to+AIDS+and+death+in+untreated+HIV-1+infection%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001525-Gupta1" id="pone.0001525-Gupta1"></a>Gupta SB, Jacobson LP, Margolick JB, Rinaldo CR, Phair JP, et al.  (2007) Estimating the Benefit of an HIV-1 Vaccine That Reduces Viral Load Set Point. J Infect Dis  195: 546â550.  <ul class="find" data-citedArticleID="1049098" data-doi="10.1086/510909"><li><a href="http://dx.doi.org/10.1086/510909" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Estimating+the+Benefit+of+an+HIV-1+Vaccine+That+Reduces+Viral+Load+Set+Point." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Estimating+the+Benefit+of+an+HIV-1+Vaccine+That+Reduces+Viral+Load+Set+Point.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001525-Schacker1" id="pone.0001525-Schacker1"></a>Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L (1998) Biological and virologic characteristics of primary HIV infection. Ann Intern Med  128: 613â620.  <ul class="find" data-citedArticleID="1049126" data-doi="10.7326/0003-4819-128-8-199804150-00001"><li><a href="http://dx.doi.org/10.7326/0003-4819-128-8-199804150-00001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Biological+and+virologic+characteristics+of+primary+HIV+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Biological+and+virologic+characteristics+of+primary+HIV+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001525-Dolan1" id="pone.0001525-Dolan1"></a>Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, et al.  (2007) CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol  8: 1324â1336.  <ul class="find" data-citedArticleID="1049080" data-doi="10.1038/ni1521"><li><a href="http://dx.doi.org/10.1038/ni1521" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CCL3L1+and+CCR5+influence+cell-mediated+immunity+and+affect+HIV-AIDS+pathogenesis+via+viral+entry-independent+mechanisms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CCL3L1+and+CCR5+influence+cell-mediated+immunity+and+affect+HIV-AIDS+pathogenesis+via+viral+entry-independent+mechanisms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001525-Baeten1" id="pone.0001525-Baeten1"></a>Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, et al.  (2007) HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis  195: 1177â1180.  <ul class="find" data-citedArticleID="1049074" data-doi="10.1086/512682"><li><a href="http://dx.doi.org/10.1086/512682" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HIV-1+subtype+D+infection+is+associated+with+faster+disease+progression+than+subtype+A+in+spite+of+similar+plasma+HIV-1+loads." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HIV-1+subtype+D+infection+is+associated+with+faster+disease+progression+than+subtype+A+in+spite+of+similar+plasma+HIV-1+loads.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001525-Kaslow1" id="pone.0001525-Kaslow1"></a>Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, et al.  (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol  126: 310â318.  <ul class="find" data-citedArticleID="1049104" data-doi="10.1093/aje/126.2.310"><li><a href="http://dx.doi.org/10.1093/aje/126.2.310" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+Multicenter+AIDS+Cohort+Study%3A+rationale%2C+organization%2C+and+selected+characteristics+of+the+participants." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+Multicenter+AIDS+Cohort+Study%3A+rationale%2C+organization%2C+and+selected+characteristics+of+the+participants.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001525-Giorgi1" id="pone.0001525-Giorgi1"></a>Giorgi JV, Cheng HL, Margolick JB, Bauer KD, Ferbas J, et al.  (1990) Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. Clin Immunol Immunopathol  55: 173â186.  <ul class="find" data-citedArticleID="1049094" data-doi="10.1016/0090-1229(90)90096-9"><li><a href="http://dx.doi.org/10.1016/0090-1229(90)90096-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Quality+control+in+the+flow+cytometric+measurement+of+T-lymphocyte+subsets%3A+the+multicenter+AIDS+cohort+study+experience.+The+Multicenter+AIDS+Cohort+Study+Group." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Quality+control+in+the+flow+cytometric+measurement+of+T-lymphocyte+subsets%3A+the+multicenter+AIDS+cohort+study+experience.+The+Multicenter+AIDS+Cohort+Study+Group.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.XML" value="93541"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.PDF" value="207288"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t001.PNG_L" value="209667"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t001.PNG_M" value="100767"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t001.PNG_S" value="19900"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t001.TIF" value="1070092"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t001.PNG_I" value="128484"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t002.PNG_L" value="272496"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t002.PNG_M" value="157017"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t002.PNG_S" value="16352"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t002.TIF" value="1288620"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t002.PNG_I" value="47743"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t003.PNG_L" value="235103"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t003.PNG_M" value="133136"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t003.PNG_S" value="15132"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t003.TIF" value="1250698"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.t003.PNG_I" value="40304"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g001.PNG_L" value="364933"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g001.PNG_M" value="27457"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g001.PNG_S" value="7062"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g001.TIF" value="730380"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g001.PNG_I" value="18973"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g002.PNG_L" value="371395"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g002.PNG_M" value="28789"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g002.PNG_S" value="6890"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g002.TIF" value="747818"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001525.g002.PNG_I" value="20669"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001525&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001525" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001525&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001525&volume=&issue=&title=Lack of Evidence for Changing Virulence of HIV-1 in North America&author_name=Joshua%20T.%20Herbeck%2C%20Geoffrey%20S.%20Gottlieb%2C%20Xiuhong%20Li%2C%20Zheng%20Hu%2C%20Roger%20Detels%2C%20John%20Phair%2C%20Charles%20Rinaldo%2C%20Lisa%20P.%20Jacobson%2C%20Joseph%20B.%20Margolick%2C%20James%20I.%20Mullins&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001525" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525&amp;t=Lack%20of%20Evidence%20for%20Changing%20Virulence%20of%20HIV-1%20in%20North%20America" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525&title=Lack%20of%20Evidence%20for%20Changing%20Virulence%20of%20HIV-1%20in%20North%20America&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525&amp;title=Lack%20of%20Evidence%20for%20Changing%20Virulence%20of%20HIV-1%20in%20North%20America" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001525&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Lack of Evidence for Changing Virulence of HIV-1 in North America';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001525';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Lack%20of%20Evidence%20for%20Changing%20Virulence%20of%20HIV-1%20in%20North%20America http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001525" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001525" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">























          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22AIDS%22" title="Search for articles in the subject area:'AIDS'"><div class="flagText">AIDS</div></a>
              <div data-categoryid="47633" data-articleid="25876"
                   data-categoryname="AIDS"
                   class="flagImage" title="Flag 'AIDS' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antiretroviral+therapy%22" title="Search for articles in the subject area:'Antiretroviral therapy'"><div class="flagText">Antiretroviral therapy</div></a>
              <div data-categoryid="32515" data-articleid="25876"
                   data-categoryname="Antiretroviral therapy"
                   class="flagImage" title="Flag 'Antiretroviral therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cohort+studies%22" title="Search for articles in the subject area:'Cohort studies'"><div class="flagText">Cohort studies</div></a>
              <div data-categoryid="25265" data-articleid="25876"
                   data-categoryname="Cohort studies"
                   class="flagImage" title="Flag 'Cohort studies' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22HIV%22" title="Search for articles in the subject area:'HIV'"><div class="flagText">HIV</div></a>
              <div data-categoryid="42663" data-articleid="25876"
                   data-categoryname="HIV"
                   class="flagImage" title="Flag 'HIV' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22HIV-1%22" title="Search for articles in the subject area:'HIV-1'"><div class="flagText">HIV-1</div></a>
              <div data-categoryid="42865" data-articleid="25876"
                   data-categoryname="HIV-1"
                   class="flagImage" title="Flag 'HIV-1' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Opportunistic+infections%22" title="Search for articles in the subject area:'Opportunistic infections'"><div class="flagText">Opportunistic infections</div></a>
              <div data-categoryid="48457" data-articleid="25876"
                   data-categoryname="Opportunistic infections"
                   class="flagImage" title="Flag 'Opportunistic infections' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22T+cells%22" title="Search for articles in the subject area:'T cells'"><div class="flagText">T cells</div></a>
              <div data-categoryid="40147" data-articleid="25876"
                   data-categoryname="T cells"
                   class="flagImage" title="Flag 'T cells' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Viral+load%22" title="Search for articles in the subject area:'Viral load'"><div class="flagText">Viral load</div></a>
              <div data-categoryid="21755" data-articleid="25876"
                   data-categoryname="Viral load"
                   class="flagImage" title="Flag 'Viral load' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=8075'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=4808'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=2269&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=21445">Referee comments: Referee 1 (Kenrad Nelson)</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
